盐酸法舒地尔对急性脑梗死患者血清超敏C反应蛋白和血管内皮生长因子的影响(3)
 |
| 第1页 |
参见附件。
[6] Kimura R， Nakase H， Tamaki R， et al. Vascular endothelial growth factor antagonist reduces brain edema formation and veoous infaretion. Stroke，2005，36(6)：1259.
[7] Gora-KupilasK， Josko J. The neuroproteetive function of vasclllar endothelial growth factor(VEGF). Folia Neuropathol，2005，43(1)：31-39.
[8] Shvin M， Krupinski J， Slowik A， et al. Serial measurement of vascular endothelial growth factor and transforming growth factor-β1 in serum of patients with acute ischemic stoke.Stoke，2000，31(8)：1863-1870.
[9] Shah DI， Singh M. Involvement of Rho-kinase in experimentalvascular endothelial dysfunction. Mol Cell Bioehem，2006，283(8)：191-199.
[10] Satoh S， Toshima Y， Ikegakil， et al. Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gethils. Brain Res，2007，1128：175-180.
[11] Rikitake Y， Kim H H， Huang Z， et al. Inhibition of Rho kinase(ROCK)leads tO increased cerebral blood flow and stroke protection. Stroke，2005，36：2251-2257.
[12] Wettschureck N. Ormanns S.Rho/Rho- kinase mediated signaling in physiology and pathphysiofogy. J Mol Med，2002，80(10)：629- 638.
[13] Satoh S， Toshinm Y， Ikegaki I， et al. Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal deathin gerbils. Brain Re，2007，1128：175-180.
[14] Shibuya M， Hirai S， Seto M， et al. Effects offasudil in acute ischemic stroke： Results of a prospective placobo-controlled doubleblind trial. Neurology，2005，238(12)：31-39.
您现在查看是摘要介绍页，详见PDF附件(3785kb)。